CIK 0001501989 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue (USD) | 76.2 M | 101.2 M | 53.2 M |
| Net income (USD) | -17.4 M | -569000 | -99.3 M |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 4/A | FORM 4/A | 2025-11-06 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-06 | S-8 | S-8 | |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 4 | FORM 4 | 2026-08-03 |
| 2026-08-05 | 3 | FORM 3 | 2026-08-03 |
| 2026-08-03 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-30 | 4 | FORM 4 | 2026-07-24 |
| 2026-07-30 | 3 | FORM 3 | 2026-07-24 |
| 2026-07-27 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-27 | 8-K | 8-K items 5.02 | 2026-07-24 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 8-K | 8-K items 5.02,5.03,5.07,9.01 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-22 | 4 | 4 | 2026-06-17 |
| 2026-06-17 | 4 | 4 | 2026-06-15 |
| 2026-06-03 | 8-K | 8-K items 1.01 | 2026-05-29 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A |
Forms on file (last 1,000): 4 356, 8-K 131, SC 13G/A 44, 3 38, 10-Q 33, SCHEDULE 13G/A 23, SC 13G 21, S-8 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CTMX (0.002 USD), /gw/filings/filings?ticker=CTMX&form=8-K, /gw/filings/facts?ticker=CTMX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange